Published in BMC Dermatol on September 20, 2004
Effect of increased pigmentation on the antifibrotic response of human skin to UV-A1 phototherapy. Arch Dermatol (2008) 1.59
Mechanism of UV-related carcinogenesis and its contribution to nevi/melanoma. Expert Rev Dermatol (2007) 0.98
Screening for in vitro phototoxic activity of methanol extracts of Croton campestris A., Ocimum gratissimum L. & Cordia verbenaceae DC. Indian J Med Res (2010) 0.82
Phototherapy in Scleroderma. Dermatol Ther (Heidelb) (2016) 0.75
Photochemically Controlled Drug Dosing from a Polymeric Scaffold. Pharm Res (2017) 0.75
Rippled skin, fasciitis, and joint contractures. J Am Acad Dermatol (2008) 0.75
Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature (1995) 6.85
Apoptosis. Immunol Today (1993) 4.23
Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature (1996) 3.83
Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine (Baltimore) (1980) 3.20
Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol (2001) 2.71
Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci U S A (1993) 2.44
High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol (1997) 1.96
Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol (1990) 1.90
Medium-dose UVA1 cold-light phototherapy in the treatment of severe atopic dermatitis. J Am Acad Dermatol (1999) 1.48
Scleroderma: immunopathogenesis and treatment. Immunol Today (1998) 1.46
Mechanisms of lipid peroxidation. J Free Radic Biol Med (1985) 1.36
Low-dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol (1998) 1.25
Potential involvement of free radical reactions in ultraviolet light-mediated cutaneous damage. Photochem Photobiol (1987) 1.21
UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res (1991) 1.17
The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol (2001) 1.14
Disabling pansclerotic morphea of children. Arch Dermatol (1980) 1.11
Th2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens. Arthritis Rheum (2002) 1.09
UVA-induced autocrine stimulation of fibroblast-derived collagenase/MMP-1 by interrelated loops of interleukin-1 and interleukin-6. Photochem Photobiol (1994) 1.07
Ultraviolet light therapy in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) (1985) 1.07
Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: results of a preliminary study. J Am Acad Dermatol (2002) 1.05
Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J Invest Dermatol (1992) 1.03
High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol (1992) 1.02
Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med (1997) 1.02
Ultraviolet-A1 (340-400 nm) irradiation therapy in systemic lupus erythematosus. Lupus (1996) 0.99
Clinical features and therapy of lichen sclerosus et atrophicus affecting males. Clin Exp Dermatol (1987) 0.99
Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med (1986) 0.99
The carcinogenic effect of UVA irradiation. J Invest Dermatol (1983) 0.98
Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA). Bone Marrow Transplant (1996) 0.97
Sclerodermatous graft-vs-host disease: clinical and pathological study of 17 patients. Arch Dermatol (2002) 0.97
Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea. Pediatr Dermatol (2001) 0.97
Ultraviolet-A1 irradiation decreases clinical disease activity and autoantibodies in patients with systemic lupus erythematosus. Clin Exp Rheumatol (1994) 0.96
Suggested mechanisms of action of UVA phototherapy in morphea: a molecular study. Photodermatol Photoimmunol Photomed (2004) 0.96
Scleromyxedema. A variant of Lichen myxedematosus. Arch Dermatol (1966) 0.94
Alterations in human epidermal Langerhans cells by ultraviolet radiation: quantitative and morphological study. Br J Dermatol (2003) 0.93
Linear scleroderma 'en coup de sabre' treated with topical calcipotriol and cream psoralen plus ultraviolet A. J Eur Acad Dermatol Venereol (2003) 0.93
Ultraviolet A1 phototherapy. Br J Dermatol (2003) 0.92
Ultraviolet A irradiation stimulates collagenase production in cultured human fibroblasts. J Invest Dermatol (1992) 0.92
Treatment of localised scleroderma by UVA1 phototherapy. Lancet (1995) 0.92
Induction of a caffeine-sensitive S-phase cell cycle checkpoint by psoralen plus ultraviolet A radiation. Oncogene (2003) 0.90
Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon. J Rheumatol (1993) 0.90
Low dose UVA1 phototherapy in disabling pansclerotic morphoea of childhood. Br J Dermatol (1997) 0.89
PUVA therapy in disabling pansclerotic morphoea of children. Br J Dermatol (1995) 0.88
PUVA treatment of scleromyxoedema. Br J Dermatol (1984) 0.88
Porphyria and scleroderma: a clinical and laboratory review of 12 patients. Australas J Dermatol (1983) 0.88
Methoxsalen and ultraviolet A radiation in treatment of chronic cutaneous graft-versus-host reaction. J Am Acad Dermatol (1985) 0.88
Phototherapy for scleroderma: biologic rationale, results, and promise. Curr Opin Rheumatol (2002) 0.87
Longterm ultraviolet-A1 irradiation therapy in systemic lupus erythematosus. J Rheumatol (1997) 0.87
PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients. Arch Dermatol (1996) 0.87
Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts. Lancet (1997) 0.87
Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method. Dermatology (2003) 0.87
UVA irradiation stimulates the synthesis of various matrix-metalloproteinases (MMPs) in cultured human fibroblasts. Exp Dermatol (1993) 0.86
UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial. Ann Rheum Dis (2001) 0.86
Low-dose UVA1 phototherapy in systemic sclerosis: effects on acrosclerosis. J Am Acad Dermatol (2004) 0.86
Treatment of localised scleroderma with PUVA bath photochemotherapy. Lancet (1994) 0.86
Effects of low dose ultraviolet A-1 phototherapy on morphea. Photodermatol Photoimmunol Photomed (2001) 0.86
Apoptosis in different cutaneous manifestations of lupus erythematosus. Br J Dermatol (2001) 0.85
Vascular damage and lack of angiogenesis in systemic sclerosis skin. Clin Rheumatol (2003) 0.85
Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis. J Am Acad Dermatol (2000) 0.85
PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen. J Am Acad Dermatol (1986) 0.85
Functional and phenotypic analysis of T lymphocytes cloned from the skin of patients with systemic sclerosis. Clin Exp Immunol (1990) 0.85
Singlet oxygen is an early intermediate in cytokine-dependent ultraviolet-A induction of interstitial collagenase in human dermal fibroblasts in vitro. FEBS Lett (1997) 0.85
PUVA-induced apoptosis involves mitochondrial dysfunction caused by the opening of the permeability transition pore. FEBS Lett (2002) 0.85
Psoralen plus ultraviolet-A-bath photochemotherapy as an adjunct treatment modality in cutaneous chronic graft versus host disease. Photodermatol Photoimmunol Photomed (2002) 0.85
The expression of matrix metalloproteinase-1 mRNA induced by ultraviolet A1 (340-400 nm) is phototherapy relevant to the glutathione (GSH) content in skin fibroblasts of systemic sclerosis. J Dermatol (2003) 0.84
Dendritic cells in cutaneous lupus erythematosus: a clue to the pathogenesis of lesions. Histopathology (1994) 0.84
Consensus workshop on the toxic effects of long-term PUVA therapy. Arch Dermatol (1998) 0.84
[Lichen sclerosus et atrophicus]. Hautarzt (1991) 0.84
Immunopathology and the gene therapy of lupus. Gene Ther (2003) 0.84
[UV-A-1 therapy of subacute cutaneous lupus erythematosus]. Hautarzt (1993) 0.83
Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study. J Am Acad Dermatol (1994) 0.83
Eosinophilic fasciitis. Dermatol Online J (2003) 0.83
Immediate and delayed apoptotic cell death mechanisms: UVA versus UVB and UVC radiation. Cell Death Differ (1994) 0.83
PUVA-cream photochemotherapy for the treatment of localized scleroderma. J Am Acad Dermatol (2000) 0.83
Psoralen UVA therapy for linear and generalized morphea. J Am Acad Dermatol (1997) 0.83
Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells. J Am Acad Dermatol (2001) 0.83
Effects of the isoflavone 4',5,7-trihydroxyisoflavone (genistein) on psoralen plus ultraviolet A radiation (PUVA)-induced photodamage. Carcinogenesis (2002) 0.83
Guidelines for topical PUVA: a report of a workshop of the British photodermatology group. Br J Dermatol (2000) 0.83
Low-dose broad-band UVA in morphea using a new method for evaluation. Photodermatol Photoimmunol Photomed (2000) 0.82
Relationship of p53 with other oncogenes, cytokines and systemic lupus erythematosus activity. Tumour Biol (2003) 0.82
What is light? Photodermatol Photoimmunol Photomed (2002) 0.82
Phototherapy in pediatric patients. Pediatr Dermatol (2003) 0.82
Photochemotherapy improves chronic cutaneous graft-versus-host disease. J Am Acad Dermatol (1990) 0.82
Opposing effects of UVA1 phototherapy on the expression of bcl-2 and p53 in atopic dermatitis. Arch Dermatol Res (2001) 0.82
UVA1 irradiation induces deoxyribonuclease dependent apoptosis in cutaneous T-cell lymphoma in vivo. Photodermatol Photoimmunol Photomed (2000) 0.82
High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE-binding cells in lesional skin of patients with atopic eczema. J Invest Dermatol (1996) 0.82
Acrosclerosis in patients with systemic sclerosis responds to low-dose UV-A1 phototherapy. Arch Dermatol (2000) 0.82
Immunohistochemical analysis of chronic discoid and subacute cutaneous lupus erythematosus--relation to immunopathological mechanisms. Br J Dermatol (1995) 0.82
Low dose versus medium dose UV-A1 treatment in severe atopic eczema. Acta Derm Venereol (1995) 0.82
Phototherapy in the treatment of cutaneous graft-versus-host disease. Our preliminary experience in resistant patients. Transplantation (1995) 0.81
Bath-PUVA therapy in three patients with scleredema adultorum. J Am Acad Dermatol (1998) 0.81
PUVA therapy for chronic cutaneous graft-vs-host disease. Arch Dermatol (1991) 0.81
Extracorporeal photochemotherapy in systemic sclerosis and severe morphea. Dermatology (1995) 0.81
Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease. Haematologica (2003) 0.81
[Ultraviolet-A1 (UVA1) phototherapy in lichen sclerosus et atrophicus]. Hautarzt (2001) 0.81
Changes in collagen I and collagen III metabolism in patients with generalized atopic eczema undergoing medium-dose ultraviolet A1 phototherapy. Br J Dermatol (2000) 0.80
A clinical observation of scleredema adultorum and its relationship to diabetes. J Dermatol (1998) 0.80
Eosinophilic fasciitis treated with psoralen-ultraviolet A bath photochemotherapy. Br J Dermatol (2000) 0.80
Cream PUVA therapy for scleredema adultorum. Br J Dermatol (2000) 0.80
UV transmission measurements of small skin specimens with special quartz cuvettes. Dermatology (2000) 0.80
Mononuclear cells in atopic dermatitis in vivo: immunomodulation of the cutaneous infiltrate by medium-dose UVA1 phototherapy. Eur J Med Res (2002) 0.80
Thick legs - not always lipedema. J Dtsch Dermatol Ges (2012) 3.35
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet (2010) 2.61
Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet (2011) 1.80
Applications of optical coherence tomography in dermatology. J Dermatol Sci (2005) 1.72
Clinical features and efficacy of antimalarial treatment for reticular erythematous mucinosis: a case series of 11 patients. Arch Dermatol (2011) 1.59
Narrowband UVB phototherapy in skin conditions beyond psoriasis. J Am Acad Dermatol (2005) 1.51
Merkel cell polyomavirus DNA in persons without merkel cell carcinoma. Emerg Infect Dis (2009) 1.45
Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking. Arch Dermatol (2009) 1.44
HPV-73- and HPV-82 positive anal margin carcinoma with secondary ulcerating Herpes simplex-virus 2 infection. J Dtsch Dermatol Ges (2010) 1.38
What do we know of post-thrombotic syndrome? Current status of post-thrombotic syndrome in adults. J Dtsch Dermatol Ges (2009) 1.38
Resting pressure exerted by round knitted moderate-compression stockings on the lower leg in clinical practice--results of an experimental study. Dermatol Surg (2009) 1.38
Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi. Cell Tissue Res (2012) 1.35
Up-regulation of transforming growth factor-beta3 and extracellular matrix proteins in acquired reactive perforating collagenosis. J Am Acad Dermatol (2009) 1.26
Endoscopic thoracic sympathectomy for severe hyperhidrosis: impact of restrictive denervation on compensatory sweating. Ann Thorac Surg (2006) 1.25
In vivo optical coherence tomography of basal cell carcinoma. J Dermatol Sci (2007) 1.25
A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations. Hum Mol Genet (2011) 1.24
Lipolysis of lipomas in patients with familial multiple lipomatosis: an ultrasonography-controlled trial. J Cutan Med Surg (2007) 1.23
Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer. Mol Carcinog (2011) 1.22
MicroRNAs and the skin: tiny players in the body's largest organ. J Dermatol Sci (2008) 1.20
Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma. J Dermatol Sci (2012) 1.17
Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up. Hum Mol Genet (2012) 1.17
Emergency medical kits on board commercial aircraft: a comparative study. Travel Med Infect Dis (2010) 1.17
In vivo data of epidermal thickness evaluated by optical coherence tomography: effects of age, gender, skin type, and anatomic site. J Dermatol Sci (2006) 1.15
Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer. Cancer Invest (2010) 1.14
Coexistence of lichen sclerosus and morphea: a retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center. J Am Acad Dermatol (2012) 1.11
Characterization of benign and malignant melanocytic skin lesions using optical coherence tomography in vivo. J Am Acad Dermatol (2007) 1.09
Clinical and serological characteristics of progressive facial hemiatrophy: a case series of 12 patients. J Am Acad Dermatol (2006) 1.06
Medical emergencies on board commercial airlines: is documentation as expected? Crit Care (2012) 1.06
A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort. Ann Rheum Dis (2010) 1.05
Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men. J Invest Dermatol (2008) 1.05
Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: results of a preliminary study. J Am Acad Dermatol (2002) 1.05
Treatment of psoriasis with fumaric acid esters (Fumaderm). J Dtsch Dermatol Ges (2007) 1.05
Calciphylaxis: a severe complication of renal disease. CMAJ (2011) 1.04
Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infection. J Am Acad Dermatol (2005) 1.04
Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma. Arch Dermatol (2005) 1.03
[AWMF Guideline no. 013/066. Diagnosis and therapy of circumscribed scleroderma]. J Dtsch Dermatol Ges (2009) 1.02
A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol (2006) 1.01
Cutaneous lesions of the external ear. Head Face Med (2008) 1.01
Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: a multicenter study. J Invest Dermatol (2008) 1.01
Penile intraepithelial neoplasia is frequent in HIV-positive men with anal dysplasia. J Invest Dermatol (2008) 1.00
Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin. Int Arch Allergy Immunol (2008) 0.99
Detection of clonal T cells in the circulation of patients with nephrogenic systemic fibrosis. Arch Dermatol (2009) 0.98
Promising results from a pilot study on compression treatment of ear keloids. J Cutan Med Surg (2011) 0.98
Age related changes of human skin investigated with histometric measurements by confocal laser scanning microscopy in vivo. Skin Res Technol (2002) 0.97
Influence of wetness on the ultraviolet protection factor (UPF) of textiles: in vitro and in vivo measurements. Photodermatol Photoimmunol Photomed (2002) 0.97
Surgical treatment of axillary hyperhidrosis: a study comparing liposuction cannulas with a suction-curettage cannula. Ann Plast Surg (2006) 0.96
MicroRNA in non-melanoma skin cancer. Cancer Biomark (2012) 0.96
Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men. Arch Dermatol (2006) 0.95
Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvement. Exp Dermatol (2011) 0.94
A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci. Hum Mol Genet (2013) 0.94
Angiokeratoma Fordyce of the glans penis: combined treatment with erbium: YAG and 532 nm KTP (frequency doubled neodynium: YAG) laser. J Dermatol (2004) 0.93
Regression of cutaneous warts in a patient with WILD syndrome following recombinant quadrivalent human papillomavirus vaccination. Arch Dermatol (2010) 0.93
Histological and clinical findings in different surgical strategies for focal axillary hyperhidrosis. Dermatol Surg (2008) 0.93
High association of human herpesvirus 8 in large-plaque parapsoriasis and mycosis fungoides. Arch Dermatol (2008) 0.93
A randomized, controlled, double-blind study evaluating melanin-encapsulated liposomes as a chromophore for laser hair removal of blond, white, and gray hair. Ann Plast Surg (2007) 0.93
Treatment of acquired perforating dermatosis with narrowband ultraviolet B. J Am Acad Dermatol (2005) 0.93
Minichromosome maintenance proteins are useful adjuncts to differentiate between benign and malignant melanocytic skin lesions. J Am Acad Dermatol (2009) 0.92
Expression of proliferative biomarkers in anal intraepithelial neoplasia of HIV-positive men. J Am Acad Dermatol (2009) 0.92
Skin disorders in association with monoclonal gammopathies. Eur J Med Res (2005) 0.92
Safety and efficiency of perilesional sclerotherapy in leg ulcer patients with postthrombotic syndrome and/or oral anticoagulation with phenprocoumon. J Dtsch Dermatol Ges (2006) 0.91
A human papillomavirus-associated disease with disseminated warts, depressed cell-mediated immunity, primary lymphedema, and anogenital dysplasia: WILD syndrome. Arch Dermatol (2008) 0.91
Merkel cell polyomavirus infection in HIV-positive men. Arch Dermatol (2011) 0.91
Increased sensitivity of patch testing by standardized tape stripping beforehand: a multicentre diagnostic accuracy study. Contact Dermatitis (2010) 0.91
Human polyomaviruses 6, 7, 9, 10 and Trichodysplasia spinulosa-associated polyomavirus in HIV-infected men. J Gen Virol (2014) 0.91
Indoor tanning in North Rhine-Westphalia Germany: a self-reported survey. Photodermatol Photoimmunol Photomed (2009) 0.91
The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis. PLoS One (2013) 0.91
Acute skin alterations following ultraviolet radiation investigated by optical coherence tomography and histology. Arch Dermatol Res (2005) 0.90
A case of poikiloderma vasculare atrophicans, a rare variant of cutaneous T-cell lymphoma, responding to extracorporeal photopheresis. J Am Acad Dermatol (2005) 0.90
A 9-Valent HPV Vaccine in Women. N Engl J Med (2015) 0.90
A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis. Arthritis Res Ther (2012) 0.90
Wrong diagnosis erysipelas: hypodermitis - case series and review of literature. J Dtsch Dermatol Ges (2008) 0.90